The diagnostic firm Digene Corp. is raising $56 million in gross proceeds by way of a public offering announced after Wednesday's market close. Management at the Gaithersburg, Md.-based company ...

-- Digene shareholders who tendered Digene shares in the exchange offer and elected to receive cash consideration or did not make an election in respect of those shares, representing approximately ...

Digene Corp., a Gaithersburg company that sells DNA-based tests to detect diseases, is jumping into the growing market for drug-research tools that analyze genetic activity. Digene announced yesterday ...

Sales of Digene Corp.'s two-in-one test for cervical cancer jumped 66 percent in its fiscal first quarter, sending the biotechnology company's revenue and earnings higher. For the quarter ended Sept.

NEW YORK, Jan 12 (Reuters) - Digene Corp's new chief executive officer said on Friday the company could not afford to remain "a one-product company" and would aim to disclose a strategy of moving ...

FRANKFURT, Aug 6 (Reuters) - Qiagen NV , fresh from a $1.6 billion acquisition of Digene Corp, posted a 60 percent rise in quarterly net earnings on Monday on strong demand for its genetic test kits ...